AQSE Quarterly Update Q1 2025

Q1 offered little respite from unsettling global events and macroeconomic uncertainty, however we were pleased to see two new companies join our Access segment with another to follow shortly.

Reassuringly, interest is building from companies seeking alternatives to private fundraising and utilising a public market that has been designed specifically for them is providing a useful option that many are now becoming aware of. Demonstrating this renewed confidence, we were pleased to see such a strong turn out for our latest “Journey to IPO” event. In fact, across the five events held in Q1, we were delighted to see such an enthusiastic turnout from investors, issuers, advisors and prospective issuers.

In terms of trading for Q1, with c£40m traded across the exchange and Apex volumes up c20%, there is still appetite from investors for interesting stories and exciting growth companies.
Thank you again for your continued support and with a raft of new initiatives about to be launched, we are excited about what the rest of 2025 has to offer. Watch this space…

Good Life Plus Plc announced the creation of a Convertible Loan Note for up to £2m, with an initial subscription of £1m already made by Boatside Investments. Read more

SulNOx Group PLC announced the signing of an agreement with Eastern Pacific Shipping Pte Ltd (EPS), one of the world's largest privately-owned shipping companies. Under the Agreement, EPS will adopt SulNOxEco on at least 30 vessels for a minimum of 18 months use per vessel. Read more

All Things Considered Group Plc provided an update on trading for the financial year ended 31 December 2024. The Group highlighted that revenue increased by 100% to circa £50m (FY23: £24.1m) with adjusted operating EBITDA anticipated to be approximately £1.5m (FY23: loss of £0.46m). Read more

Oberon Investments Group plc announced that it has raised £2.5m before expenses, through a placing via Oberon Capital, of 55,555,554 new ordinary shares. The Company says the proceeds will support the expansion of the Company's key business divisions to accelerate growth across the Group as well as for working capital purposes. Read more

EDX Medical Group Plc announced it has developed a new ‘super test’ for prostate cancer in an effort to revolutionise screening and diagnosis of the disease and accelerate personalised treatment for patients. Read more
The Company then approved the issue of 21,428,571 new ordinary shares to raise £3m to support the acceleration of regulatory preparation and scaling up of production of a new prostate cancer 'super test'. Read more

TAP Global Group Plc announced it has raised gross proceeds of £1m by way of a placing of 50,000,000 new ordinary shares in the Company. Read more

Equipmake Holdings PLC announced it has signed a development agreement with JCB for an initial six-month period. Equipmake will apply its expertise in electrification systems integration and collaborate on developing a bespoke power electronics package to support JCB's new product development. Read more

Ananda Pharma Plc announced an achievement of a manufacturing milestone, the final technical batch of MRX1 CBD drug candidate to support data for the Investigational Medicinal Product Dossier has been completed. The next MRX1 manufacturing batch will be delivered to clinical trial sites and dosed into trial participants. Read more

RentGuarantor Holdings PLC announced its annual audited financial accounts and report for the year to 31 December 2024. The Company highlighted that revenues increased by 72% to £1.27m (FY23: £741,000) and tenant contracts rose by 50% to 1,687. Read more

Cardiogeni PLC is a UK clinical stage biotechnology company developing novel heart failure medicines. Cardiogeni joined our Access segment on the 31st January raising £1.44m.

Supersearch Plus plc is a frozen seafood wholesale and importer based in Hong Kong. Supersearch Plus joined our Access segment on the 25th March raising £279k.

Aquis spoke on a panel with Enterprise Investment Scheme Association (EISA) and Female Founders Rise (FFR) discussing exit strategies and the IPO alternative.

Aquis Exchange PLC hosted our second International Women’s Day Breakfast Debate in partnership with DebateMate focused on the motion: “This house believes International Women’s Day has become a symbolic gesture rather than a driver for change”. Students from Hornsey School for Girls, alongside Aquis’ own Adele and Sakeena, passionately debated the topic, delivering a thought-provoking and engaging event.

Educating the management teams of our issuers on the role and experience of a Market Maker. We discussed the do’s and dont’s for an RNS, understanding your share price, and did you know a market maker has less than 3 minutes to read the whole RNS!

This was the first “Journey to IPO” of 2025, and we welcomed Novum Securities, Druces LLP, PKF International, Retail Book and Ananda Pharma Plc to present to an audience of prospective companies on navigating an IPO on the Aquis Stock Exchange. The event attracted numerous founders who are considering an IPO and who we are now in regular communication with.

The AQSE team attended the Master Investor Show this year interacting with some of the 4,000 retail investor attendees. Co-heads of Business Development, Sara-Louise and Steve, spoke on a panel titled “Investing for Growth” with Melissa, CEO of Ananda Pharma, who were also in attendance.

Panel with EISA and Female Founders Rise discussing exit strategies.

22nd April (projected)
Welcome Smarter Web Company to the Access segment of the AQSE growth market

June
Journey to IPO

29th June
Small Cap Awards